ABEO 8-K: Acquisition
Filed with the SEC on · accession 0001493152-26-050606
ABEO filed a 8-K (current report) with the SEC on Nov 9, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Summary of the filing
Abeona Therapeutics acquired substantially all assets related to APT-1011, a clinical-stage treatment for eosinophilic esophagitis, from Ellodi Pharmaceuticals for $20 million in stock plus up to $60 million in milestone payments and tiered royalties.
Key details
✦ Ask GOAX AI about this filing — what it means for ABEO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ABEO?
Click hereFrequently asked questions
What did ABEO file with the SEC on Nov 9, 2026?
ABEO filed a 8-K (Acquisition). Abeona Therapeutics acquired substantially all assets related to APT-1011, a clinical-stage treatment for eosinophilic esophagitis, from Ellodi Pharmaceuticals for $20 million in stock plus up to $60 million in milestone payments and tiered royalties.
What does a acquisition mean for ABEO stock?
A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other ABEO SEC filings
- 8-K · SEC filingNov 9, 2026
- SCHEDULE 13D · Activist campaignOct 23, 2026
- 8-K · SEC filingSep 15, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 8-K · SEC filingAug 13, 2026
- 10-Q · Material agreementAug 13, 2026
- 424B3 · Secondary offeringJul 10, 2026
- 8-K · Board changeJun 12, 2026
- 8-K · Board changeJun 12, 2026
- 8-K · Regulatory actionJun 4, 2026
Get alerts when ABEO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days